Drug firm Dr Reddy's Laboratories today said its consolidated net profit has gone up by 25.38% to Rs 262.74 crore for the first quarter ended June 30, 2011, over the same period previous fiscal.
The company had a net profit of Rs 209.55 crore in the same period previous fiscal, Dr Reddy's Laboratories said in a filing to the Bombay Stock Exchange (BSE).
The company's net income from sales and services stood at Rs 1,978.32 crore for the first quarter ended June 30, 2011, compared to Rs 1,683.13 crore for the same period previous fiscal.
On a standalone basis, the company reported a net profit of Rs 454.05 crore for the first quarter ended June 30, 2011, compared to Rs 244.48 crore in the same period previous fiscal.
The company's net sales stood at Rs 1,675.71 crore for the first quarter on a standalone basis, compared to Rs 1,256.22 crore in the same period previous fiscal.
During the quarter, the company launched 39 new generic products, filed 31 new product registrations and nine drug master files globally, it said.
Shares of Dr Reddy's Laboratories today closed at Rs 1,570 on the BSE in late afternoon trade, down 1.87 from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app